Shenzhen kangtai hepatitis b vaccine-induced 2 deaths in Hunan Province sold to Hunan, Guangdong, Guizhou | | Shenzhen kangtai | 3 province _ hepatitis b vaccine news

December 13, according to the website of the State food and Drug Administration news, recently, Shenzhen kangtai biological products Corporation produces recombinant hepatitis b vaccine (Saccharomyces cerevisiae) in Hunan 2 deaths occur after vaccination.

Food Drug Administration and the local authorities are currently organized to investigate. For controlled medication risk, decided to suspend the Shenzhen kangtai biological products company limited batch of recombinant hepatitis b vaccine in C201207088 and C201207090 (Saccharomyces cerevisiae) is used.

The investigation, these two batch of product sales to Hunan, Guangdong and Guizhou provinces, food drug administration requirements, Guangdong, Guizhou, Hunan province food and Drug Administration to immediately notify the relevant units within the jurisdiction be suspended to prevent similar incidents.

(Original title: Shenzhen kangtai 2 death cases caused by hepatitis b vaccine have been sold to Hunan, Guangdong, Guizhou 3 provinces)

(Edit: SN064)December 13, 2013 China News Network(深圳康泰乙肝疫苗致湖南2人死 销往湘粤黔3省|深圳|康泰|乙肝疫苗_新闻资讯

　　中新网12月13日电 据国家食品药品监督管理总局网站消息，近期，深圳康泰生物制品股份有限公司生产的重组乙型肝炎疫苗(酿酒酵母)在湖南接种后出现2例死亡病例。

　　目前食药监总局和当地有关部门正组织对此进行调查。为控制用药风险，决定暂停深圳康泰生物制品股份有限公司批号为C201207088和 C201207090的重组乙型肝炎疫苗(酿酒酵母)使用。

　　经查，上述二个批号的产品销售到湖南、广东、贵州三省，食药监总局要求湖南、广东、贵州省食品药品监督管理局立即通知辖区内有关单位暂停使用，防止出现类似事件。

(原标题：深圳康泰乙肝疫苗致2例死亡病例 已销往湘粤黔3省)

（编辑：SN064）2013年12月13日16:28中国新闻网)